Submission Details
| 510(k) Number | K222888 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 23, 2022 |
| Decision Date | August 11, 2023 |
| Days to Decision | 322 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K222888 is an FDA 510(k) clearance for the BlueStar CGM insulin dose calculator, a Continuous Glucose Monitor Informed Insulin Dose Calculator (Class II — Special Controls, product code QRX), submitted by Welldoc, Inc. (Columbia, US). The FDA issued a Cleared decision on August 11, 2023, 322 days after receiving the submission on September 23, 2022. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1358.
| 510(k) Number | K222888 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 23, 2022 |
| Decision Date | August 11, 2023 |
| Days to Decision | 322 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | QRX — Continuous Glucose Monitor Informed Insulin Dose Calculator |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1358 |
| Definition | A Continuous Glucose Monitor (cgm)-informed Insulin Dose Calculator Is A Software Device That Calculates Suggested Insulin Doses Based On Cgm Values And/or Other Relevant Information. |